# Lilly (Eli)
> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
## Record
| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:ed5c886b-f007-4eec-951c-0141de4aae25 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/eli-lilly-co |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 59 |
| Claims under review | 1 |
| Evidence records | 31 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-16T04:45:02.848559+00:00 |
| Last reviewed | 2026-10-16T04:45:02.848559+00:00 |
## Identity
- Legal name: ELI LILLY & Co
- Display name: Lilly (Eli)
## Alpha Governance Record
| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-16T07:50:18.618947+00:00 |
| Completeness | 0.455 |
| Record Quality | 0.798 |
| Directors | 13 |
| Committees | 12 |
| Governance events | 30 |
| Entity class | public_company |
## Section coverage
| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | PUBLISHED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |
## Board
- Carolyn R. Bertozzi, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:11
- David Ricks: Chair. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:10
- Gabrielle Sulzberger: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Audit (member); Audit; Directors and Corporate Governance (member); Directors and Corporate Governance (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:12
- J. Erik Fyrwald: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Science and Technology (member); Talent and Compensation (member); Talent and Compensation; Science and Technology (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:13
- Jamere Jackson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Audit (chair); Audit · Chair; Directors and Corporate Governance (member); Directors and Corporate Governance (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:14
- Jon Moeller: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: Audit (member); Audit; Directors and Corporate Governance (member); Directors and Corporate Governance (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:15
- Juan R. Luciano: Lead Independent Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Directors and Corporate Governance (chair); Directors and Corporate Governance · Chair; Talent and Compensation (member); Talent and Compensation (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:16
- Katherine Baicker, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:17
- Kimberly Johnson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Ethics and Compliance (member); Talent and Compensation (member); Talent and Compensation; Ethics and Compliance (member). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:18
- Mary Lynne Hedley, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:19
- Ralph Alvarez: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. Committees: Audit (member); Audit; Talent and Compensation · Chair (member); Talent and Compensation (chair). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:20
- William G. Kaelin Jr., M.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-03-20. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:21
- William Kaelin, Jr.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2012-01-01. Committees: Directors and Corporate Governance (member); Directors and Corporate Governance; Science and Technology · Chair (member); Science and Technology (chair). claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:22
## Committees
- Audit (audit). Chair: Jamere Jackson. Members: Jamere Jackson (chair, current); Gabrielle Sulzberger (member, current); Jon Moeller (member, current); Ralph Alvarez (member, current). committee_id=alpha:committee:eli-lilly-co:audit
- Audit · Chair; Directors and Corporate Governance (audit). Chair: NOT_PUBLISHED. Members: Jamere Jackson (member, current). committee_id=alpha:committee:eli-lilly-co:audit-chair-directors-and-corporate-governance
- Audit; Directors and Corporate Governance (audit). Chair: NOT_PUBLISHED. Members: Gabrielle Sulzberger (member, current); Jon Moeller (member, current). committee_id=alpha:committee:eli-lilly-co:audit-directors-and-corporate-governance
- Audit; Talent and Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Ralph Alvarez (member, current). committee_id=alpha:committee:eli-lilly-co:audit-talent-and-compensation-chair
- Directors and Corporate Governance (nominating_governance). Chair: Juan R. Luciano. Members: Juan R. Luciano (chair, current); Gabrielle Sulzberger (member, current); Jamere Jackson (member, current); Jon Moeller (member, current); William Kaelin, Jr. (member, current). committee_id=alpha:committee:eli-lilly-co:directors-and-corporate-governance
- Directors and Corporate Governance · Chair; Talent and Compensation (compensation). Chair: NOT_PUBLISHED. Members: Juan R. Luciano (member, current). committee_id=alpha:committee:eli-lilly-co:directors-and-corporate-governance-chair-talent-and-compensation
- Directors and Corporate Governance; Science and Technology · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: William Kaelin, Jr. (member, current). committee_id=alpha:committee:eli-lilly-co:directors-and-corporate-governance-science-and-technology-chair
- Ethics and Compliance (other). Chair: NOT_PUBLISHED. Members: Kimberly Johnson (member, current). committee_id=alpha:committee:eli-lilly-co:ethics-and-compliance
- Science and Technology (technology). Chair: William Kaelin, Jr.. Members: William Kaelin, Jr. (chair, current); J. Erik Fyrwald (member, current). committee_id=alpha:committee:eli-lilly-co:science-and-technology
- Talent and Compensation (compensation). Chair: Ralph Alvarez. Members: Ralph Alvarez (chair, current); J. Erik Fyrwald (member, current); Juan R. Luciano (member, current); Kimberly Johnson (member, current). committee_id=alpha:committee:eli-lilly-co:talent-and-compensation
- Talent and Compensation; Ethics and Compliance (compensation). Chair: NOT_PUBLISHED. Members: Kimberly Johnson (member, current). committee_id=alpha:committee:eli-lilly-co:talent-and-compensation-ethics-and-compliance
- Talent and Compensation; Science and Technology (compensation). Chair: NOT_PUBLISHED. Members: J. Erik Fyrwald (member, current). committee_id=alpha:committee:eli-lilly-co:talent-and-compensation-science-and-technology
## Executive leadership
- Adrienne Brown: Executive Vice President and President, Lilly Immunology [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:23
- Anat Hakim: Executive Vice President, General Counsel and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:24
- Carole Ho: Executive Vice President and President, Lilly Neuroscience [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:25
- Daniel Skovronsky: Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Laboratories [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:26
- David Ricks: Chair, President, and Chief Executive Officer (CEO) [CEO]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:27
- Diogo Rau: Executive Vice President and Chief Information and Digital Officer. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:28
- Edgardo Hernandez: Executive Vice President and President, Manufacturing Operations [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:29
- Eric Dozier: Executive Vice President, Chief People Officer [CHRO]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:30
- Ilya Yuffa: Executive Vice President and President, Lilly USA and Global Customer Capabilities [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:31
- Jacob Van Naarden: Executive Vice President, President, Lilly Oncology and Head of Corporate Business Development [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:32
- Kenneth Custer: Executive Vice President and President, Lilly Cardiometabolic Health [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:33
- Lucas Montarce: Executive Vice President and Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:34
- Melissa Seymour: Executive Vice President, Global Quality. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:35
- Patrik Jonsson: Executive Vice President and President, Lilly International [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:36
## Governance events
- DIRECTOR_APPOINTED: Carolyn R. Bertozzi, Ph.D. seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:17hlkig18tmdxc
- DIRECTOR_APPOINTED: Gabrielle Sulzberger seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1bw06071fuvq6n
- DIRECTOR_APPOINTED: J. Erik Fyrwald seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:y1kr4d9m7f7v
- DIRECTOR_APPOINTED: Jamere Jackson seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:ti0r3d1bl0k7n
- DIRECTOR_APPOINTED: Juan R. Luciano seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1qwesnj171hclb
- LEAD_DIRECTOR_CHANGED: Juan R. Luciano lead independent director of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:zo8jyr1w9pxwv
- DIRECTOR_APPOINTED: Katherine Baicker, Ph.D. seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:c9vz9ex6llpy
- DIRECTOR_APPOINTED: Kimberly Johnson seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:19raehk1w16kk2
- DIRECTOR_APPOINTED: Mary Lynne Hedley, Ph.D. seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1kq8gmo1c33cdm
- DIRECTOR_APPOINTED: Ralph Alvarez seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1mgq4s21o8zt0q
- DIRECTOR_APPOINTED: William G. Kaelin Jr., M.D. seat on Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1c17zcb12o68m7
- COMMITTEE_CREATED: Audit · Chair; Directors and Corporate Governance committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:l2smndb3k837
- COMMITTEE_MEMBER_ADDED: Jamere Jackson member of Audit · Chair; Directors and Corporate Governance, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:100l0d5czo25z
- COMMITTEE_CREATED: Audit; Directors and Corporate Governance committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1xaqkub1q8m1yx
- COMMITTEE_MEMBER_ADDED: Gabrielle Sulzberger member of Audit; Directors and Corporate Governance, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1ungq3kxzsxj
- COMMITTEE_CREATED: Audit; Talent and Compensation · Chair committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:44kk1u18dp5mi
- COMMITTEE_MEMBER_ADDED: Ralph Alvarez member of Audit; Talent and Compensation · Chair, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:164mj6rbxb4jz
- COMMITTEE_CREATED: Directors and Corporate Governance · Chair; Talent and Compensation committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1opxmd71c050tz
- COMMITTEE_MEMBER_ADDED: Juan R. Luciano member of Directors and Corporate Governance · Chair; Talent and Compensation, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:lez34z1frfbzr
- COMMITTEE_CREATED: Talent and Compensation; Ethics and Compliance committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1b0kgia7qnipq
- COMMITTEE_MEMBER_ADDED: Kimberly Johnson member of Talent and Compensation; Ethics and Compliance, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1182zjqmqdaaw
- COMMITTEE_CREATED: Talent and Compensation; Science and Technology committee of Lilly (Eli), effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:13de6651gjmak3
- COMMITTEE_MEMBER_ADDED: J. Erik Fyrwald member of Talent and Compensation; Science and Technology, effective 2026-03-20. Effective: 2026-03-20. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:11tnuwq1eo0z82
- DIRECTOR_APPOINTED: Jon Moeller seat on Lilly (Eli), effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1bex4ir13yswm1
- COMMITTEE_MEMBER_ADDED: Jon Moeller member of Audit; Directors and Corporate Governance, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1h2bfv1k2bn2l
- DIRECTOR_APPOINTED: David Ricks seat on Lilly (Eli), effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:63rzx2gn9kpq
- BOARD_CHAIR_CHANGED: David Ricks chairs board Lilly (Eli), effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:sls4961rqqnx2
- DIRECTOR_APPOINTED: William Kaelin, Jr. seat on Lilly (Eli), effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:1cimw8wvmfjt6
- COMMITTEE_CREATED: Directors and Corporate Governance; Science and Technology · Chair committee of Lilly (Eli), effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:192kyaemkzjp2
- COMMITTEE_MEMBER_ADDED: William Kaelin, Jr. member of Directors and Corporate Governance; Science and Technology · Chair, effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T04:45:02.848559+00:00. event_id=alpha:event:transition:y4atc0ubqjd6
## Scoped resources
- `alpha://company/eli-lilly-co` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record
- `alpha://company/eli-lilly-co/identity` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=identity
- `alpha://company/eli-lilly-co/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=corporate-structure
- `alpha://company/eli-lilly-co/board` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=board
- `alpha://company/eli-lilly-co/committees` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=committees
- `alpha://company/eli-lilly-co/leadership` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=leadership
- `alpha://company/eli-lilly-co/ownership` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=ownership
- `alpha://company/eli-lilly-co/financials` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=financials
- `alpha://company/eli-lilly-co/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=capital-structure
- `alpha://company/eli-lilly-co/compensation` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=compensation
- `alpha://company/eli-lilly-co/governance` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=governance
- `alpha://company/eli-lilly-co/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=shareholder-governance
- `alpha://company/eli-lilly-co/audit` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=audit
- `alpha://company/eli-lilly-co/legal` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=legal
- `alpha://company/eli-lilly-co/risk` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=risk
- `alpha://company/eli-lilly-co/cyber` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=cyber
- `alpha://company/eli-lilly-co/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=ai-governance
- `alpha://company/eli-lilly-co/agents` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=agents
- `alpha://company/eli-lilly-co/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=ecosystem
- `alpha://company/eli-lilly-co/events` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=events
- `alpha://company/eli-lilly-co/relationships` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=relationships
- `alpha://company/eli-lilly-co/assessments` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=assessments
- `alpha://company/eli-lilly-co/evidence` (contract): https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record§ion=evidence
## Role modules
- NOT_ASSERTED
## Attention
- NO_RECORDS_FOUND
## Committee data
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:38: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:jamere-jackson","name":"Jamere Jackson"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:39: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:gabrielle-sulzberger","name":"Gabrielle Sulzberger"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:40: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jon-moeller","name":"Jon Moeller"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:41: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:ralph-alvarez","name":"Ralph Alvarez"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:43: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:juan-r-luciano","name":"Juan R. Luciano"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:44: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:gabrielle-sulzberger","name":"Gabrielle Sulzberger"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:45: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jamere-jackson","name":"Jamere Jackson"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:46: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jon-moeller","name":"Jon Moeller"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:47: `{"kind":"committee_appointment","original_name":"Directors and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:william-kaelin-jr","name":"William Kaelin, Jr."},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:49: `{"kind":"committee_appointment","original_name":"Ethics and Compliance","category":"other","role":"member","person":{"alpha_id":"alpha:person:kimberly-johnson","name":"Kimberly Johnson"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:51: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"chair","person":{"alpha_id":"alpha:person:william-kaelin-jr","name":"William Kaelin, Jr."},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:52: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:j-erik-fyrwald","name":"J. Erik Fyrwald"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:54: `{"kind":"committee_appointment","original_name":"Talent and Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:ralph-alvarez","name":"Ralph Alvarez"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:55: `{"kind":"committee_appointment","original_name":"Talent and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:j-erik-fyrwald","name":"J. Erik Fyrwald"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:56: `{"kind":"committee_appointment","original_name":"Talent and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:juan-r-luciano","name":"Juan R. Luciano"},"source_id":"board_seats"}`
- Claim alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:57: `{"kind":"committee_appointment","original_name":"Talent and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kimberly-johnson","name":"Kimberly Johnson"},"source_id":"board_seats"}`
## Leadership
- David Ricks: Chair. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dbd763f05a328231373a04f53cb7e34b0c1f2f6ff7b1d1446e22655cde0bea13.
- Carolyn R. Bertozzi, Ph.D.: Director. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:11. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afdcf1522906ff7cd99650671d36a788c0a2bbc2384bc2e7ad892a5c96666ca3.
- Gabrielle Sulzberger: Director, Audit; Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:12. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6f35099c1291158a9addc4a0a50e2118b08e3fe1ca78f72723bb1a6d5a1a541.
- J. Erik Fyrwald: Director, Talent and Compensation; Science and Technology. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:13. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce0ed99cf945cc8b381a90ec2e8c56de1f453e44d6725685938cfc26a2340234.
- Jamere Jackson: Director, Audit · Chair; Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:14. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff0b6d4eb95617660a96b052ea5b31ff4bf77acd4b885a5bdd7b69929c322267.
- Jon Moeller: Director, Audit; Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:15. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2d93a47596e17644c4bcea5aad8b625bba64903d0edc6b61dbfa0068bea2f7ac.
- Juan R. Luciano: Lead Independent Director, Directors and Corporate Governance · Chair; Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:16. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b459027c37cb8a9013662e0b07e857425a717e7a5b11f3bf5b6624cc9ced92ce.
- Katherine Baicker, Ph.D.: Director. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:17. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6326cbfa637699b5f7848e437804a64fd3cdc34df2c96b5f2d63de0f48345f1.
- Kimberly Johnson: Director, Talent and Compensation; Ethics and Compliance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:18. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4a30c098a4a68e57eafaf7740a5eea207dee07f5a712687bb73d3957f6e80584.
- Mary Lynne Hedley, Ph.D.: Director. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:19. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c725f196ab40e8dfeaee09d14e12e788792f57b370209581b9e86f3b9ed80f75.
- Ralph Alvarez: Director, Audit; Talent and Compensation · Chair. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:20. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6ec4b33661a2eef359a5176343bdbc7a2d4a12e807fca67b8c0e2a9bf34df44c.
- William G. Kaelin Jr., M.D.: Director. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:21. Valid from: 2026-03-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:314fcb01d93646e1b1470c75eae79bb8f212dd4f354c1f72f50efcaa38b10ce8.
- William Kaelin, Jr.: Director, Directors and Corporate Governance; Science and Technology · Chair. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:22. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cffbb81b357bbe1614740a5ab14d015520e27f8590c7e92e5432b2a0c157f1d0.
- Adrienne Brown: Executive Vice President and President, Lilly Immunology. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:334b0745cf84f53aa5f5d0fda5cba627b952c82477b730c40c7ec94e7bcd4531.
- Anat Hakim: Executive Vice President, General Counsel and Secretary. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:343df0b317f9d1e9978e9c350f18fdcabb40abb4a1f3f292c009e9d056e117e8.
- Carole Ho: Executive Vice President and President, Lilly Neuroscience. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ad62fa3d97af3c6c29f92650b3bf17c9b48f101547bef29f1c7202d5c666d08a.
- Daniel Skovronsky: Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Laboratories. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:299846c67451289b7468682bbf6e2271eca789ba4299cff991517fed7bff1a85.
- David Ricks: Chair, President, and Chief Executive Officer (CEO). Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:571a3ae2a24c839ce4b2614fd38c75681b66eea7a926baa05d9cc5db6fe2d493.
- Diogo Rau: Executive Vice President and Chief Information and Digital Officer. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dbbcca4ee29ed0233d90717206029da707483f3a5cca82b43f01a20819f85751.
- Edgardo Hernandez: Executive Vice President and President, Manufacturing Operations. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6bcf221e6c5cbef2ceb6c5c67bcafb23b4731dd21078a0614aae3ef80c18a8f.
- Eric Dozier: Executive Vice President, Chief People Officer. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0a31559e6fb655f082d3a87eec283e445815c879196b5283e6d208117d028701.
- Ilya Yuffa: Executive Vice President and President, Lilly USA and Global Customer Capabilities. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e269a8ea551874e338daad716989e73eb0cbc77af878c4f3736367df6c01275d.
- Jacob Van Naarden: Executive Vice President, President, Lilly Oncology and Head of Corporate Business Development. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:55506d0bdb37d7ce7e46f5ffcaa79265a53b486bc4c3d7328df99ae54cd84a24.
- Kenneth Custer: Executive Vice President and President, Lilly Cardiometabolic Health. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02ae298c8e40d956c1c847839ceae7474cb8695ee35cf0f9ac23f9947e1ba5e9.
- Lucas Montarce: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:21a7ae2723c0aaf715aa0ad7c4393ff9d301fbcbddbe659020e438240086a473.
- Melissa Seymour: Executive Vice President, Global Quality. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c25184b065c1e34928156525bde08ae0108daa40dc0ef6144d183197f7cac39.
- Patrik Jonsson: Executive Vice President and President, Lilly International. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:leadership_role:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fef8c0c6217d0f2edc9141992ee09c46be42c3fb8dcfb525755c9a67e9302d6d.
## Roles
- PUBLISHED
## Governance
- NOT_ASSERTED
## Board committees
- Audit: Chair Jamere Jackson; Members Jamere Jackson (Chair); Gabrielle Sulzberger; Jon Moeller; Ralph Alvarez. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:37. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Directors and Corporate Governance: Chair Juan R. Luciano; Members Juan R. Luciano (Chair); Gabrielle Sulzberger; Jamere Jackson; Jon Moeller; William Kaelin, Jr.. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:42. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Ethics and Compliance: Chair not stated; Members Kimberly Johnson. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:48. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Science and Technology: Chair William Kaelin, Jr.; Members William Kaelin, Jr. (Chair); J. Erik Fyrwald. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:50. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Talent and Compensation: Chair Ralph Alvarez; Members Ralph Alvarez (Chair); J. Erik Fyrwald; Juan R. Luciano; Kimberly Johnson. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_record:53. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
## Financials
- NOT_ASSERTED
## Workforce
- NOT_ASSERTED
## Market and index context
- S&P 500 (SPX). Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:index_membership:58. Valid from: 1970-12-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a.
## Legal Name
- ELI LILLY & Co. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11.
## Entity Status
- Public listing published. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11.
## Official Website
- https://www.lilly.com. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:official_website:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e35bbf6e0ccb75ab8426bc334cf18605a3a87350df5637af4b29dc23bcd83c10.
## Published Fact
- US. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11.
- IN. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11.
- Healthcare. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11.
- Drug Manufacturers. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11.
- https://www.lilly.com. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:published_fact:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e35bbf6e0ccb75ab8426bc334cf18605a3a87350df5637af4b29dc23bcd83c10.
## Committee Appointment
- Jamere Jackson: chair, Audit. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Gabrielle Sulzberger: member, Audit. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Jon Moeller: member, Audit. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:40. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Ralph Alvarez: member, Audit. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:41. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Juan R. Luciano: chair, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:43. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Gabrielle Sulzberger: member, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:44. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Jamere Jackson: member, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:45. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Jon Moeller: member, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:46. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- William Kaelin, Jr.: member, Directors and Corporate Governance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:47. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Kimberly Johnson: member, Ethics and Compliance. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:49. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- William Kaelin, Jr.: chair, Science and Technology. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:51. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- J. Erik Fyrwald: member, Science and Technology. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:52. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Ralph Alvarez: chair, Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:54. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- J. Erik Fyrwald: member, Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:55. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Juan R. Luciano: member, Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:56. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
- Kimberly Johnson: member, Talent and Compensation. Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:committee_appointment:57. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378.
## Security Listing
- LLY (NYSE). Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:security_listing:59. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11.
- LLY (SIX). Claim: alpha:claim:company:ed5c886b-f007-4eec-951c-0141de4aae25:security_listing:60. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11.
## Coverage states
| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
## Public sources
- alpha:projection-evidence:a1384cbc8b528ee5a3d5c70c14d0474f189f1ddfb07215f524e9e8fc13c7ee11: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/eli-lilly-co).
- alpha:projection-evidence:e35bbf6e0ccb75ab8426bc334cf18605a3a87350df5637af4b29dc23bcd83c10: [ELI LILLY & Co Form 10-K (filed 2026-02-12)](https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/lly-20251231.htm).
- alpha:projection-evidence:document:dbd763f05a328231373a04f53cb7e34b0c1f2f6ff7b1d1446e22655cde0bea13: [Eli Lilly director board source](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:afdcf1522906ff7cd99650671d36a788c0a2bbc2384bc2e7ad892a5c96666ca3: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:e6f35099c1291158a9addc4a0a50e2118b08e3fe1ca78f72723bb1a6d5a1a541: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:ce0ed99cf945cc8b381a90ec2e8c56de1f453e44d6725685938cfc26a2340234: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:ff0b6d4eb95617660a96b052ea5b31ff4bf77acd4b885a5bdd7b69929c322267: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:2d93a47596e17644c4bcea5aad8b625bba64903d0edc6b61dbfa0068bea2f7ac: [Eli Lilly director board source](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:b459027c37cb8a9013662e0b07e857425a717e7a5b11f3bf5b6624cc9ced92ce: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:f6326cbfa637699b5f7848e437804a64fd3cdc34df2c96b5f2d63de0f48345f1: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:4a30c098a4a68e57eafaf7740a5eea207dee07f5a712687bb73d3957f6e80584: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:c725f196ab40e8dfeaee09d14e12e788792f57b370209581b9e86f3b9ed80f75: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:6ec4b33661a2eef359a5176343bdbc7a2d4a12e807fca67b8c0e2a9bf34df44c: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:314fcb01d93646e1b1470c75eae79bb8f212dd4f354c1f72f50efcaa38b10ce8: [LLY DEF 14A director slate](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:cffbb81b357bbe1614740a5ab14d015520e27f8590c7e92e5432b2a0c157f1d0: [Eli Lilly director board source](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:document:334b0745cf84f53aa5f5d0fda5cba627b952c82477b730c40c7ec94e7bcd4531: LLY executive roster source.
- alpha:projection-evidence:document:343df0b317f9d1e9978e9c350f18fdcabb40abb4a1f3f292c009e9d056e117e8: LLY executive roster source.
- alpha:projection-evidence:document:ad62fa3d97af3c6c29f92650b3bf17c9b48f101547bef29f1c7202d5c666d08a: LLY executive roster source.
- alpha:projection-evidence:document:299846c67451289b7468682bbf6e2271eca789ba4299cff991517fed7bff1a85: LLY executive roster source.
- alpha:projection-evidence:document:571a3ae2a24c839ce4b2614fd38c75681b66eea7a926baa05d9cc5db6fe2d493: LLY executive roster source.
- alpha:projection-evidence:document:dbbcca4ee29ed0233d90717206029da707483f3a5cca82b43f01a20819f85751: LLY executive roster source.
- alpha:projection-evidence:document:c6bcf221e6c5cbef2ceb6c5c67bcafb23b4731dd21078a0614aae3ef80c18a8f: LLY executive roster source.
- alpha:projection-evidence:document:0a31559e6fb655f082d3a87eec283e445815c879196b5283e6d208117d028701: LLY executive roster source.
- alpha:projection-evidence:document:e269a8ea551874e338daad716989e73eb0cbc77af878c4f3736367df6c01275d: LLY executive roster source.
- alpha:projection-evidence:document:55506d0bdb37d7ce7e46f5ffcaa79265a53b486bc4c3d7328df99ae54cd84a24: LLY executive roster source.
- alpha:projection-evidence:document:02ae298c8e40d956c1c847839ceae7474cb8695ee35cf0f9ac23f9947e1ba5e9: LLY executive roster source.
- alpha:projection-evidence:document:21a7ae2723c0aaf715aa0ad7c4393ff9d301fbcbddbe659020e438240086a473: LLY executive roster source.
- alpha:projection-evidence:document:2c25184b065c1e34928156525bde08ae0108daa40dc0ef6144d183197f7cac39: LLY executive roster source.
- alpha:projection-evidence:document:fef8c0c6217d0f2edc9141992ee09c46be42c3fb8dcfb525755c9a67e9302d6d: LLY executive roster source.
- alpha:projection-evidence:72315c0e2bfed1af0e8bf7151f090d5a5f269442c802da66b844fc505f7d9378: [Audit](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm).
- alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a: [S&P 500](https://www.slickcharts.com/sp500).
## Rights
| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
## Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
## Alternate representations
- [Canonical profile](https://registry.alpha.ac/companies/eli-lilly-co)
- [Public Markdown](https://registry.alpha.ac/companies/eli-lilly-co.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/eli-lilly-co?format=jsonld)
- MCP resource: `alpha://companies/eli-lilly-co` at https://mcp.alpha.ac/mcp
## Connected governance records
Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.
## Critical-risk oversight
Snapshot as of 2026-10-16T07:50:18.362057+00:00; recorded 2026-10-16T07:50:18.362057+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.Lilly (Eli), for agents
The same record as the human view, as a structured object any agent can read and cite. Reading is open to every agent, model, and tool, with no key and no account. Signing and transparency logging are not yet published for this record.
- Alpha ID
- alpha:company:ed5c886b-f007-4eec-951c-0141de4aae25
- Version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ceRecorded Oct 16, 2026
- Content hash
- Not yet signed
- Signature
- Not yet signed
- Transparency log
- Not yet signed
- Freshness
- ObservedChecked Oct 16, 2026. Reviewed Oct 16, 2026
- Read access
- OpenNo key for public retrieval
- Processing basis
- Public recordDoctrine
Read
OpenOne canonical URL. The Accept header or a file suffix selects the format. Every format renders the same Claims and carries the same record version.
curl -H "Accept: application/json" https://registry.alpha.ac/companies/eli-lilly-coTrustCheck and Governance Receipts
Agent tierIllustrative. TrustChecks run in the private enterprise overlay. The example below is generated for this entity class and does not reference this record. Contract: TrustCheck and Governance Receipts v0.1.
Agents about to act ask a question, not for a document. A TrustCheck evaluates the AuthorityGrant objects behind a proposed action and returns allow, deny, require_approval, or insufficient_evidence. The source system acts, and a GovernanceReceipt records what the agent relied on.
- allow, deny
- The AuthorityGrant and policy decide. Reason codes name the rule.
- require_approval
- An entitled human records the decision. Customer policy sets the threshold, never an Eval.
- insufficient_evidence
- No authority is registered. Alpha never infers permission to act.
curl https://www.alpha.ac/v1/action-intents \
-H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" \
-d '{
"schema_version": "2026-08-29",
"environment": "test",
"actor": { "alpha_id": "alpha:account:self", "type": "alpha_account" },
"principal": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"organization": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"proposed_action": { "type": "purchase_order.commit", "description": "Accept an order placed by an agent claiming company authority." },
"requested_authority": ["purchase_order.commit"]
}'
# then
curl https://www.alpha.ac/v1/trust-checks -H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" -d '{ "action_intent_id": "<from the previous response>" }'{
"schema_version": "2026-08-29",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"decision": "insufficient_evidence",
"explanation": "No AuthorityGrant names this agent and organization.",
"reason_codes": [
"authority_grant_missing"
],
"evaluated_authority": {
"authority_grants": []
},
"policy_version": "trustcheck.registry-claim.test.v0.1",
"integrity_state": "recorded",
"limitations": [
"Illustrative example. No TrustCheck was run for this record."
]
}{
"schema_version": "2026-08-29",
"receipt_id": "alpha:receipt:illustrative-0001",
"environment": "test",
"actor": {
"alpha_id": "alpha:account:self",
"type": "alpha_account"
},
"agent": {
"provider": {
"alpha_id": "alpha:company:example-agent-provider",
"type": "provider"
},
"product": {
"alpha_id": "alpha:agent-product:example-procurement-agent",
"type": "agent_product"
},
"deployment": {
"alpha_id": "alpha:agent-deployment:example-deployment",
"type": "agent_deployment"
},
"use_case": {
"alpha_id": "alpha:agent-use-case:example-purchase-order",
"type": "agent_use_case"
},
"workflow": "Illustrative purchase order commitment"
},
"principal": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"sponsor": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"action_intent_id": "alpha:action-intent:illustrative-0001",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"authority_grant_references": [],
"action_intent": {
"type": "purchase_order.commit"
},
"affected_alpha_ids": [
"alpha:company:example-issuer"
],
"trust_check_decision": "insufficient_evidence",
"policy_version": "trustcheck.registry-claim.test.v0.1",
"rule_references": [
{
"reason_code": "authority_grant_missing",
"rule_id": "trustcheck.authority_grant_missing",
"policy_ref": "trustcheck.registry-claim.test.v0.1",
"control_ref": null,
"grant_policy_references": []
}
],
"integrity": "Illustrative. Not issued, not signed."
}Connect
Open readEvery surface reads the same published record. No surface holds its own copy of the facts.
// claude_desktop_config.json, Cursor, or any MCP client
{
"mcpServers": {
"alpha": { "url": "https://mcp.alpha.ac/mcp" }
}
}
// This record as an MCP resource
alpha://companies/eli-lilly-coalpha://companies/eli-lilly-coThis record as an MCP resourcehttps://registry.alpha.ac/api/public/companies/eli-lilly-co?format=recordThe same record over HTTP
Subscribe to changes
Agent tier, previewNo public subscription endpoint is published yet. Event delivery is part of Agent tier access, in preview. Access and availability.
DIRECTOR_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)LEAD_DIRECTOR_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_CREATEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_MEMBER_ADDEDDerived governance event published on this record (alpha-governance-event-derivation-v2)BOARD_CHAIR_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)
{
"specversion": "1.0",
"type": "ac.alpha.registry.DIRECTOR_APPOINTED",
"source": "https://registry.alpha.ac/companies/eli-lilly-co",
"subject": "alpha:company:ed5c886b-f007-4eec-951c-0141de4aae25",
"data": {
"record_version": "public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce",
"note": "Subscription delivery is Agent tier, preview. Not yet available publicly."
}
}Versions and changes
OpenRecords are versioned. Derived governance events on this record are listed below with the version that publishes them. Effective is the world time the derivation states; Recorded is when Alpha detected the event. Content hashes and log entries appear once records are signed.
| Version | Effective | Recorded | Content hash | Log entry | What changed |
|---|---|---|---|---|---|
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Carolyn R. Bertozzi, Ph.D. seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Gabrielle Sulzberger seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | J. Erik Fyrwald seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Jamere Jackson seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Juan R. Luciano seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Juan R. Luciano lead independent director of Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Katherine Baicker, Ph.D. seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Kimberly Johnson seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Mary Lynne Hedley, Ph.D. seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Ralph Alvarez seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | William G. Kaelin Jr., M.D. seat on Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Audit · Chair; Directors and Corporate Governance committee of Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Jamere Jackson member of Audit · Chair; Directors and Corporate Governance, effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Audit; Directors and Corporate Governance committee of Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Gabrielle Sulzberger member of Audit; Directors and Corporate Governance, effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Audit; Talent and Compensation · Chair committee of Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Ralph Alvarez member of Audit; Talent and Compensation · Chair, effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Directors and Corporate Governance · Chair; Talent and Compensation committee of Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Juan R. Luciano member of Directors and Corporate Governance · Chair; Talent and Compensation, effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Talent and Compensation; Ethics and Compliance committee of Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Kimberly Johnson member of Talent and Compensation; Ethics and Compliance, effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Talent and Compensation; Science and Technology committee of Lilly (Eli), effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Mar 20, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | J. Erik Fyrwald member of Talent and Compensation; Science and Technology, effective 2026-03-20. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2024 | Oct 16, 2026 | Not yet signed | Not yet signed | Jon Moeller seat on Lilly (Eli), effective 2024-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2024 | Oct 16, 2026 | Not yet signed | Not yet signed | Jon Moeller member of Audit; Directors and Corporate Governance, effective 2024-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | David Ricks seat on Lilly (Eli), effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | David Ricks chairs board Lilly (Eli), effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2012 | Oct 16, 2026 | Not yet signed | Not yet signed | William Kaelin, Jr. seat on Lilly (Eli), effective 2012-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2012 | Oct 16, 2026 | Not yet signed | Not yet signed | Directors and Corporate Governance; Science and Technology · Chair committee of Lilly (Eli), effective 2012-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2012 | Oct 16, 2026 | Not yet signed | Not yet signed | William Kaelin, Jr. member of Directors and Corporate Governance; Science and Technology · Chair, effective 2012-01-01. |
Access, rights, and the public-role doctrine
Facts are open. Rights travel with every Claim and every Evidence record, so an agent sees the same terms whichever format it reads.
| Capability | Access | Agents |
|---|---|---|
| Alpha Disclosure sample | public | human process |
| Alpha public website | public | retrievable now |
| Alpha Standard, methodology, and research | public | retrievable now |
| Alpha Profiles (public executive and company records) | public | retrievable now |
| Public HTTP endpoints described by OpenAPI 3.1 | public | retrievable now |
| Alpha MCP public discovery and read-only capabilities | public | retrievable now |
| Alpha AI Readiness Eval | public | human process |
| Alpha Platform | approved access | requires approved access |
| Alpha API (authenticated operations) | approved access | requires approved access |
| Alpha MCP premium capabilities | approved access | requires approved access |
| Alpha Evals and verified assessments | custom | human process |
| Alpha Council membership | custom | human process |
| Alpha Institute education, workshops, and coaching | custom | human process |
| Governance diagnostics and institutional advisory | custom | human process |
Record limitations. Every representation states these in the same words; nothing is inferred as zero.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
}
"evidence_rights": {
"evidence_records": 31,
"redistribution_allowed": 0,
"restricted_or_unknown": 31,
"classified_unknown": 31
}"data_subject": {
"basis": "public_record",
"entity": "alpha:company:ed5c886b-f007-4eec-951c-0141de4aae25",
"identity_ownership": "unclaimed",
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
},
"requests": "https://www.alpha.ac/contact"
}How agents find this
OpenThe page head and every response carry rel="alternate" links and the Registry's Link header. The list below is generated from the same list the server emits.
/.well-known/ai-catalog.jsonAlpha Agentic Resource Discovery manifest/.well-known/api-catalogapi-catalog/.well-known/webmcp.jsonAlpha WebMCP tool discovery/openapi.jsonAlpha Governance Public Intelligence API (OpenAPI 3.1)/apiAlpha Intelligence API/developersAlpha Governance Developer Platform/docs/trustcheck-receipts-v01.mdTrustCheck and Governance Receipts v0.1 test preview/docs/apiAlpha service documentation/llms.txtAlpha service docs for AI agents/agents.mdAlpha agent instructions (when to use Alpha)/api-versioning.mdAlpha public API versioning and deprecation policy/.well-known/agent-skills/index.jsonAgent Skills Index/products/accessAlpha Access and Availability/api/public/product-accessAlpha Product Access and Availability JSON/api/public/auth-capabilitiesAlpha Authentication Capabilities JSON/peopleAlpha Executive Profiles/companiesAlpha Company Profiles/people/readinessAlpha Profile Coverage and Agent Readiness/api/public/profile-readinessAlpha Public Profile Readiness JSON/api/public/profiles/steven-wolfe-pereiraAlpha Public Profile JSON Example/.well-known/agent-card.jsonA2A Agent Card/.well-known/mcp/server-card.jsonMCP Server Card/.well-known/openid-configurationOpenID Configuration/.well-known/oauth-protected-resourceOAuth Protected Resource/.well-known/oauth-authorization-serverOAuth Authorization Server (agent_auth)/.well-known/agent-registrationAgent Registration/.well-known/http-message-signatures-directoryhttp-message-signatures-directory/.well-known/jwks-rotationJWKS Rotation Policy/auth.mdAgent Authentication/llms.txtSite overview for AI agents/sitemap.xmlsitemap/api/public/agent-readinessAgent Readiness Status/api/public/company-report/osw-market-dataOSW Market Data Verification
Record map and assertion states
| Section | Anchor | Resource | State | Claims |
|---|---|---|---|---|
| Identity | #c-subject | /identity | Published | 0 |
| Corporate structure | - | /corporate_structure | Not reviewed | - |
| Board | #c-board | /board | Published | 13 |
| Committees | #c-committees | /committees | Published | 21 |
| Leadership | #c-leadership | /leadership | Published | 14 |
| Ownership | #c-control | /ownership | Not reviewed | 0 |
| Financials | #c-financials | /financials | Not reviewed | 3 |
| Capital structure | - | /capital_structure | Published | - |
| Compensation | #c-comp | /compensation | Not reviewed | 0 |
| Governance | #c-governance | /governance | Not reviewed | 0 |
| Shareholder governance | - | /shareholder_governance | Not reviewed | - |
| Audit | - | /audit | Not reviewed | - |
| Legal | #c-legal | /legal | Not reviewed | 0 |
| Risk | #c-risk | /risk | Not reviewed | 0 |
| Cyber | - | /cyber | Not reviewed | - |
| AI governance | #c-ai | /ai_governance | Not reviewed | 0 |
| Agent governance | #c-authority | /agent_governance | Restricted | 0 |
| Markets external | - | /markets_external | Published | - |
| Events | #c-history | /events | Published | 30 |
| Relationships | #c-links | /relationships | Published | 27 |
| Assessments | #c-monitor | /assessments | Published | 0 |
| Evidence | #c-evidence | /evidence | Published | 31 |
- corroboratedTwo or more independent sources agree
- source_reportedOne cited source states it
- alpha_inferenceAlpha's conclusion, with reasoning
- not_disclosedSearched, nothing found. Never rendered as false
- not_reviewedNot yet searched
- not_registeredNo authority registered with Alpha



